Home > Insider Trading > Filing (0000899243-16-026292)

Filing Details

Accession Number:: 0000899243-16-026292
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-04 15:31:14
Reporting Period:: 2016-08-02

Filing Date:: 2016-08-04
Accepted Time:: 2016-08-04 15:31:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1105533	Argos Therapeutics Inc	ARGS	Pharmaceutical Preparations (2834)	562110007

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1543084	Sander Deventer Van	C/O Forbion Capital Partners Gooimeer 2-35 1411 Dc Naarden P7		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-02	1,545,454	$0.00	6,199,961	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2016-08-02	1,159,090	$0.00	1,159,090	$5.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,159,090	2016-08-02	2021-08-02	No	4	P	Indirect

Footnotes

The reported securities were purchased by the Reporting Person for $5.50 per share of common stock and accompanying warrant. The shares of common stock and warrants were purchased in combination, with one warrant to purchase up to 0.75 of a share of common stock accompanying each share of common stock.
The reported securities purchased by the Reporting Person are held of record by ForArgos B.V.
Consists of (i) 3,749,817 shares held by ForArgos, B.V., (ii) 1,254,388 shares held by Cooperatieve AAC LS U.A. and (iii) 1,195,756 shares held by Forbion Co-Investment II Cooperatief U.A.
Forbion 1 Management B.V., the director of Cooperatieve AAC LS U.A and ForArgos, B.V., has voting and investment power over the reported securities held by Cooperatieve AAC LS U.A and ForArgos B.V., which are exercised through Forbion 1 Management B.V.'s investment committee, consisting of H. A. Slootweg, M. A. van Osch, G. J. Mulder and the Reporting Person. None of the members of the investment committee have individual voting and investment power with respect to such securities, and the members disclaim beneficial ownership of such securities except to the extent of their proportionate pecuniary interests therein. Forbion 1 Co-II Management B.V., the director of Forbion Co-Investment II Cooperatief U.A., has voting and investment power over the shares held by Forbion Co-Investment II Cooperatief U.A., which are exercised through Forbion 1 Co II Management B.V.'s investment committee, consisting of H. A. Slootweg, M. A. van Osch, G. J. Mulder and the Reporting Person.
(continued from footnote 4) None of the members of the investment committee has individual voting and investment power with respect to such shares, and the members disclaim beneficial ownership of such shares except to the extent of their pecuniary interests therein.